Sensei Biotherapeutics started at outperform with $36 stock price target at Oppenheimer

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Sensei Biotherapeutics Inc.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply